Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
PURPOSE: To determine the activity and toxicity of combined 24-hour infusion of paclitaxel with carboplatin in advanced non-small cell lung cancer. PATIENTS AND METHODS: Eligibility required measurable disease; stage III B with malignant pleural effusion or stage IV disease, with a performance statu...
Saved in:
Main Authors: | Charoentum C., Thongprasert S., Chewasakulyong B. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-38449083083&partnerID=40&md5=958bfe0f4532cb224aae8dec2269214c http://cmuir.cmu.ac.th/handle/6653943832/2143 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
by: Chaiyut Charoentum, et al.
Published: (2018) -
The Comparison of Neutropenia and Peripheral Neuropathy Condition as an Impact of 3-hours and 24-hour Paclitaxel Infusion of Paclitaxel-Carboplatin Chemotherapy on Ovarian Cancer Patients
by: Primandono Perbowo, -, et al.
Published: (2019) -
A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer
by: Sumitra Thongprasert, et al.
Published: (2018) -
Paclitaxel and carboplatin plus megestrol acetate in the treatment of advanced non-small cell lung cancer
by: Thongprasert S., et al.
Published: (2014) -
Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer
by: Ratanatharathorn V., et al.
Published: (2014)